Select country change
Shopping cart (0 , 0,00 ) Menu Search

SARS-CoV-2 Spike-E-M Mosaic Protein (Severe acute respiratory syndrome coronavirus 2 spike-envelope-membrane mosaic protein, 2019 novel coronavirus S-E-M mosaic protein, SARS-CoV-2 SEM mosaic protein, COVID-19)

Coronaviruses (CoVs), within the order Nidovirales, are enveloped, single-strand, positive-sense RNA viruses with a large genome of approximately 30 kbp in length. A human infecting coronavirus (viral pneumonia) initially known as 2019 novel coronavirus (2019-nCoV) was found in the fish market at the city of Wuhan, Hubei province of China in December 2019. The virus is now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
SARS-CoV-2 shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. SARS-CoV-2 has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the SARS-CoV-2 might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.

While bats are possibly the host of SARS-CoV-2, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the SARS-CoV-2 is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

Coronaviruses contain at least four structural proteins: Spike (S) protein, envelope (E) protein, membrane (M) protein, and nucleocapsid (N) protein.

3 results found in Proteins

Proteins
Product Size Price
SARS-CoV-2 (2019-nCoV) Spike-E-M Mosaic E.coli Recombinant

Type: Recombinant protein

New RP9720140050 0.05 mg
New RP9720140250 0.25 mg
New RP9720141000 1 mg